Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05255848

Nebulised Heparin in Patients With COVID-19 Pneumonia

Role of Nebulized Heparin in Non-severe and Severe Covid-19 Patients Admitted to COVID Complex LRH, MTI: A Randomized Controlled Trial

Sponsor: Lady Reading Hospital, Pakistan

Conditions COVID-19 Pneumonia

Interventions Unfractionated heparin

Updated 5 times since 2022 Last updated: Apr 23, 2022 Started: Jun 20, 2022 Primary completion: Aug 20, 2022 Completion: Oct 20, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on COVID-19 Pneumonia, this trial is ongoing. The trial is conducted by Lady Reading Hospital, Pakistan and has accumulated 5 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
May 2024 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Not Yet Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Not Yet Recruiting PHASE2_PHASE3
Mar 2022 — May 2022 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lady Reading Hospital, Pakistan

Data source: Lady Reading Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan